An ATP bioluminescence assay applicable to rapid fluconazole susceptibility testing of dermatophytes

Microbiology and Immunology

Volumn 41, Issue 5, 1997, Pages 377-386

  Yoshida, Tatsumi ^a   Uchida, Katsuhisa ^a   Yamaguchi, Hideyo ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

ATP bioluminescence; Dermatophytes; Fluconazole; Susceptibility testing

Indexed keywords

ADENOSINE TRIPHOSPHATE; FLUCONAZOLE; FUNGAL PROTEIN; LUCIFERASE; LUCIFERIN;

ARTICLE; BIOLUMINESCENCE; CANDIDA ALBICANS; CELL VIABILITY; CONTROLLED STUDY; DERMATOPHYTE; DILUTION; DRUG SENSITIVITY; EPIDERMOPHYTON FLOCCOSUM; FUNGUS GROWTH; MICROSPORUM; NONHUMAN; TRICHOPHYTON; TURBIDITY;

ARTHRODERMATACEAE; CANDIDA ALBICANS; EPIDERMOPHYTON FLOCCOSUM; FUNGI; MICROSPORUM; TRICHOPHYTON;

EID: 0030957957     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1997.tb01868.x     Document Type: Article

References (34)

1. Anaissie, E., Paetznick, V., and Bodey, G.P. 1991. Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob. Agents Chemother. 35: 1641-1646.
2. Asari, S., Toyokawa, M., Amino, N., Miyai, K., Matsunaga, T., and Kawasaki, K. 1991. New antifungal activity tests in vitro of fluconazole (New triazole antifungal agent) with semisolid SAAMF. JARMAM 3: 9-14.
3. Beckers, B., Lang, H.R.M., Schimke, D., and Lammers, A. 1985. Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria. Eur. J. Clin. Microbiol. 4: 556-561.
4. Cooksey, R.C., Morlock, G.P., Beggs, M., and Crawford, J.T. 1995. Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium. Antimicrob. Agents Chemother. 39: 754-756.
5. De Bersaques, J., Bjerke, J.R., Borelli, S., Brown, A.C., Cottenot, F., Daniel, F., Dupont, B., Gschnait, F., Heenen, M., Jegasothy, B.V., Kramer, M., Lapiere, C., Nelder, K.H., Olsen, E.A., Parish, L.C., Privat, Y., Savin, R.C., Schnabel, P., Shubert, B., Stenvolt, S.E., Svindland, H.B., Tschen, E., Vickers, C.F.H., Wade, A.G., Wallach, D., and Zaias, N. 1992. Comparison of oral fluconazole and topical clotrimazole in the treatment of fungal infections of the skin: European and American experience. Int. J. Dermatol. 31 (suppl. 2): 21-26.
6. De Cuyper, C., De Bersaques, J., Delescluse, J., Grigoriu, D., Haneke, E., Hay, R.J., Hentzer, B., Luger, A., Menke, H.E., and Sondergaard, J. 1992. Evaluation of four oral daily doses of fluconazole in the treatment of cutaneous mycoses. Int. J. Dermatol. 31 (suppl. 2): 8-11.
7. De Cuyper, C., Amblard, P., Austad, J., Bazex, J., Bohmann, P., De Bersaques, J., Garrel, J.B., Gjorud, M., Grosshans, E., Hanssen, L., Hjorth, N., Holzmann, H., Jeanpierre, G., Johnsen, J., Langeland, B., Langeland, J., Lauret, P., Mackie, R.M., Meiniche, K., Mork, N., Ortonne, J.P., Ruissant, A., Rosman, N., Sondergaard, J., Stuttgen, G., Svejgaard, E., and Thorvaldsen, J. 1992. Noncomparative study of fluconazole in the treatment of patients with common fungal infections of the skin. Int. J. Dermatol. 31 (suppl. 2): 17-20.
8. Fischbein, A., Haneke, E., Lancer, K., Male, O., Mohn, R., Muller, H., O'Connoly, M., Tronnier, H., and Vogel, F. 1992. Comparative evaluation of oral fluconazole and oral ketoconazole in the treatment of fungal infections of the skin. Int. J. Dermatol. 31 (suppl. 2): 12-16.
9. Fromtling, R.A., Galgiani, J.N., Pfaller, M.A., Espinel-Ingroff A., Bartizal, K.F., Bartlett, M.S., Body, B.A., Frey, C., Hall, G., Roberts, G.D., Nolte, F.B., Odds, F.C., Rinardi, M.G., Sugar, A.M., and Villareal, K. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37: 39-45.
10. Gehrt, A., Peter, J., Pizzo, P.A., and Walsh, T.J. 1995. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J. Clin. Microbiol. 33: 1302-1307.
11. Gordon, M.A., Lapa, E.W., and Passero, P.G. 1988. Improved method for azole antifungal susceptibility testing. J. Clin. Microbiol. 26: 1874-1877.
12. Hoeprich, P.D., and Finn, P.D. 1972. Obfuscation of the activity of antifungal antibiotics by culture media. J. Infect. Dis. 126: 353-361.
13. Jahn, B., Martin, E., Stueben, A., and Bhakdi, S. 1995. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4, 5-dimethyl-2-triazoyl)-2, 5-diphenyl-2H-tetrazolium bromide assay. J. Clin. Microbiol. 33: 661-667.
14. Kretschmar, M., Nichterlein, T., Kuntz, P., and Hof, H. 1996. Rapid detection of susceptibility to fluconazole in Candida species by a bioluminescence assay of intracellular ATP. Diagn. Microbiol. Infect. Dis. 25: 117-121.
15. Limb, D.I., Wheat, P.F., Hastings, J.G.M., and Spencer, R.C. 1991. Antimicrobial susceptibility testing of mycoplasmas by ATP bioluminescence. J. Med. Microbiol. 35: 89-92.
16. Limb, D.I., Wheat, P.F., Spencer, R.C., Harris, G.S., Rayner, A.B., and Watt, B. 1993. Comparison of techniques for antimicrobial susceptibility testing of mycobacteria. J. Clin. Pathol. 46: 403-407.
17. Lowry, O.H., Rosenbrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
18. McElroy, W.D., and Deluca, M.A. 1983. Firefly and bacterial luminescence: basic science and applications. J. Appl. Biochem. 5: 197-209.
19. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts; proposed standard. Document M-27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts; tentative standard. Document M-27-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
21. Nilsson, L.E., Hoffner, S.E., and Ansehn, S. 1988. Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob. Agents Chemother. 32: 1208-1212.
22. Odds, F.C. 1985. Laboratory tests for the activity of imidazole and triazole antifungal agents in vitro. Semin. Dermatol. 4: 260-279.
23. Odds, F.C., Cheesman, S.L., and Abbott, A.B. 1985. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents. Sabouraudia 23: 415-424.
24. Pfaller, M.A., Dupont, B., Kobayashi, G.S., Muller, J., Rinaldi, M.G., Espinel-Ingroff, A., Shadomy, S., Troke, P.F., Walsh, T.J., and Warnock, D.W. 1992. Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob. Agents Chemother. 36: 1805-1809.
25. Pfaller, M.A., Renaldi, M.G., Galgiani, J.N., Bartlett, M.S., Body, B.A., Espinel-Ingroff, A., Fromtling, R.A., Hall, G.S., Hughes, C.E., Odds, F.C., and Sugar, A.M. 1990. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob. Agents Chemother. 34: 1648-1654.
26. Rex, J., Pfaller, M.A., Rinaldi, M.G., Polak, A., and Galgiani, J.H. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6: 367-381.
27. Rinaldi, M.G. 1992. Laboratory evaluation of antifungal agents: a brief overview. Clin. Infect. Dis. 14 (suppl. 1): S 130-133.
28. Shadomy, S., and Pfaller, M.A. 1991. Laboratory studies with antifungal agents: susceptibility tests and quantitation in body fluid, p. 1173-1183. In Balows, A., Hausler, W.J., Jr., Harrman, K., Isenberg, H.D., and Shadomy, H.J. (eds), Manual of clinical microbiology, 5th ed, American Society for Microbiology, Washington, D.C.
29. Shiraishi, A., and Arai, T. 1979. Antifungal activity of transferrin. Sabouraudia 17: 79-83.
30. Troke, P.F. 1993. In vitro and experimental in vivo activities of fluconazole against some fungi causing cutaneous mycoses. In Rippon, J.W., and Fromtling, R.A. (eds), Cutaneous antifungal agents, 199-214, Marcel Dekker, New York/Basel/Hong Kong.
31. Troke, P.F., Andrews, R.J., Pye, G.W., and Richardson, K. 1990. Fluconazole and other azoles: translation of in vitro to in vivo and clinical efficacy. Rev. Infect. Dis. 12: S276-S280.
32. Wheat, P.F., Hastings, J.G.M., and Spencer, R.C. 1988. Rapid antibiotic susceptibility tests on Enterobacteriaceae by ATP bioluminescence. J. Med. Microbiol. 25: 95-99.
33. Wheat, P.F., Spencer, R.C., and Hastings, J.G.M. 1988. A novel luminometer for rapid antimicrobial susceptibility tests on gram-positive cocci by ATP bioluminescence. J. Med. Microbiol. 25: 95-99.
34. Yamaguchi, H., Uchida, K., Kawasaki, K., and Matsunaga, T. 1989. In vitro activity of fluconazole, a novel bistriazole antifungal agent. Jpn. J. Antibiotics 42: 1-16.